Chimeric antibodies greatly improve the immunogenicity and limitations of non-parental antibodies applications. Chimeric technologies to engineered non-IgG antibodies are necessary. Taking IgA for instance, IgA Fc receptor, FcαRI, effectively triggers cytotoxicity. More information can be found at https://non-igg-ab.creative-bi....olabs.com/non-igg-th
![image](https://ekcochat.com/upload/photos/2023/06/PasSUj6p2pJFfmyd1e8B_09_db5f6a2c33173e1b39b6937fe73751c9_image.png)